Table 2. Change in Secondary Outcome Measures After Intervention.
Randomization Groups | |||
---|---|---|---|
Control | Exercise | P-value† | |
Characteristics | (n=82) | (n=80) | |
Fitness and Diet Variables * | |||
Peak Absolute VO2, L/min | −0.01 (−0.06, 0.03) | 0.17 (0.13, 0.22) | <0.001 |
Percent Change Peak VO2, % | 0.5 (−1.93, 2.9) | 12.0 (9.5, 14.5) | <0.0001 |
Energy Intake, kcal/day | −113 (−238, 11) | −138 (−264, −11) | 0.78 |
Anthropometrics | |||
Weight, kg | 0.1 (−0.5, 0.7) | −0.6 (−1.2, 0.0) | 0.10 |
Body Fat Percent, % | 0.1 (−0.2, 0.4) | −0.4 (−0.7, −0.1) | 0.03 |
Fat Body Mass, DEXA | 0.2 (−0.3, 0.6) | −0.6 (−1.0, −0.1) | 0.02 |
Lean Body Mass, DEXA | −0.04 (−0.4, 0.3) | −0.06 (−0.4, 0.3) | 0.91 |
Abdominal Visceral Fat, kg | 0.00 (−0.1, 0.1) | −0.16 (−0.3, −0.1) | 0.07 |
Abdominal Subcutaneous Fat, kg | 0.00 (−0.3, 0.2) | −0.3 (−0.5, −0.1) | 0.16 |
Cardiovascular Disease Risk Factors | |||
LDL-C, mg/dL | 1.0 (−2.5, 4.5) | 3.0 (−0.5, 6.5) | 0.42 |
HDL-C, mg/dL | −2.4 (−3.6, −1.2) | −1.4 (−2.6, −0.2) | 0.25 |
Triglycerides, mg/dL | 0.5 (−7.5, 8.6) | 1.1 (−7.0, 9.2) | 0.92 |
Fasting Glucose, mg/dL | 0.8 (−0.6, 2.3) | 0.9 (−0.6, 2.4) | 0.92 |
Insulin, μU/mL | −0.2 (−1.0, 0.6) | −0.8 (−1.6, 0.03) | 0.34 |
Blood Pressure, mm Hg | |||
Systolic | −1.9 (−4.4, −0.7) | −4.1 (−6.7, −1.5) | 0.22 |
Diastolic | −2.1 (−3.7, −0.5) | −1.8 (−3.4, −0.2) | 0.78 |
Abbreviations: LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; VO2, volume of oxygen consumed
SI conversions: To convert LDL-C and HDL-C to mmol/L, multiply by 0.0259. To convert triglycerides to mmol/L, multiply by 0.0113. To convert glucose to mmol/L, multiply by 0.0555.
Values are expressed as fitted mean (95% CI) and are adjusted for baseline value and gender.
P-values for differences between groups determined by analysis of variance adjusted for baseline value and gender.